US expands scope of J&J’s biologic Stelara in psoriasis

16th October 2017 Uncategorised 0

US regulators have approved an expansion of Johnson & Johnson’s Stelara to include younger patients with plaque psoriasis.

More: US expands scope of J&J’s biologic Stelara in psoriasis
Source: News